![](/images/general/no_picture/200_user.png)
Robert B Beatty
Examiner (ID: 3913, Phone: (571)272-2130 , Office: P/2852 )
Most Active Art Unit | 2852 |
Art Unit(s) | 2852, 2105 |
Total Applications | 2973 |
Issued Applications | 2641 |
Pending Applications | 80 |
Abandoned Applications | 252 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18732592
[patent_doc_number] => 11801312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-31
[patent_title] => Method for the treatment of malignancies
[patent_app_type] => utility
[patent_app_number] => 17/063293
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 11946
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063293
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063293 | Method for the treatment of malignancies | Oct 4, 2020 | Issued |
Array
(
[id] => 16569182
[patent_doc_number] => 20210008188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITIONS AND METHODS FOR T CELL DELIVERY OF THERAPEUTIC MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/038676
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/038676 | COMPOSITIONS AND METHODS FOR T CELL DELIVERY OF THERAPEUTIC MOLECULES | Sep 29, 2020 | Pending |
Array
(
[id] => 16837882
[patent_doc_number] => 20210145894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => CELL-BASED THERAPY FOR THE PULMONARY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/948507
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16948507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/948507 | Cell-based therapy for the pulmonary system | Sep 20, 2020 | Issued |
Array
(
[id] => 16932828
[patent_doc_number] => 20210198717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/014688
[patent_app_country] => US
[patent_app_date] => 2020-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17014688
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/014688 | STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID | Sep 7, 2020 | Abandoned |
Array
(
[id] => 18931139
[patent_doc_number] => 11883535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Liposomal particles, methods of making same and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/011658
[patent_app_country] => US
[patent_app_date] => 2020-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14970
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17011658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/011658 | Liposomal particles, methods of making same and uses thereof | Sep 2, 2020 | Issued |
Array
(
[id] => 16513258
[patent_doc_number] => 20200392516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/010556
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010556 | COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS | Sep 1, 2020 | Pending |
Array
(
[id] => 16513279
[patent_doc_number] => 20200392537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => MEMBRANE-PENETRATING PEPTIDES TO ENHANCED TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/006629
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006629 | MEMBRANE-PENETRATING PEPTIDES TO ENHANCED TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME | Aug 27, 2020 | Pending |
Array
(
[id] => 16539397
[patent_doc_number] => 20200405810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => EFFICIENT SYSTEMIC TREATMENT OF DYSTROPHIC MUSCLE PATHOLOGIES
[patent_app_type] => utility
[patent_app_number] => 17/000867
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17000867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/000867 | EFFICIENT SYSTEMIC TREATMENT OF DYSTROPHIC MUSCLE PATHOLOGIES | Aug 23, 2020 | Pending |
Array
(
[id] => 16762628
[patent_doc_number] => 20210108209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis
[patent_app_type] => utility
[patent_app_number] => 16/997304
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997304 | Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis | Aug 18, 2020 | Pending |
Array
(
[id] => 16466763
[patent_doc_number] => 20200368300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => Combination Treatment
[patent_app_type] => utility
[patent_app_number] => 16/990036
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990036 | Combination Treatment | Aug 10, 2020 | Pending |
Array
(
[id] => 16451013
[patent_doc_number] => 20200360439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => ENGINEERED CHIMERIC GUIDE RNA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/990372
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990372 | Engineered chimeric guide RNA and uses thereof | Aug 10, 2020 | Issued |
Array
(
[id] => 16657774
[patent_doc_number] => 20210054410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => PROKARYOTIC-EUKARYOTIC HYBRID VIRAL VECTOR FOR DELIVERY OF LARGE CARGOS OF GENES AND PROTEINS INTO HUMAN CELLS
[patent_app_type] => utility
[patent_app_number] => 16/990289
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16990289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/990289 | Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells | Aug 10, 2020 | Issued |
Array
(
[id] => 16808239
[patent_doc_number] => 20210130792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA
[patent_app_type] => utility
[patent_app_number] => 16/986071
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986071
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986071 | Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA | Aug 4, 2020 | Issued |
Array
(
[id] => 18504891
[patent_doc_number] => 11702696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Conjugated polymeric particle and method of making same
[patent_app_type] => utility
[patent_app_number] => 16/938222
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 10443
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938222 | Conjugated polymeric particle and method of making same | Jul 23, 2020 | Issued |
Array
(
[id] => 18326866
[patent_doc_number] => 20230124994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF SANFILIPPO DISEASE AND OTHER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/628015
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628015
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628015 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SANFILIPPO DISEASE AND OTHER DISORDERS | Jul 16, 2020 | Abandoned |
Array
(
[id] => 16563279
[patent_doc_number] => 10888626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Lipid nanoparticle compositions and methods for mRNA delivery
[patent_app_type] => utility
[patent_app_number] => 16/931231
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17858
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931231
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931231 | Lipid nanoparticle compositions and methods for mRNA delivery | Jul 15, 2020 | Issued |
Array
(
[id] => 16726604
[patent_doc_number] => 20210093751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/922765
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922765 | METHOD AND COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE | Jul 6, 2020 | Pending |
Array
(
[id] => 16772011
[patent_doc_number] => 10983111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Human trophoblast stem cells and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/922595
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 64
[patent_no_of_words] => 11802
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922595
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922595 | Human trophoblast stem cells and uses thereof | Jul 6, 2020 | Issued |
Array
(
[id] => 16437391
[patent_doc_number] => 20200354717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A
[patent_app_type] => utility
[patent_app_number] => 16/905145
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/905145 | Materials and methods for treatment of usher syndrome type 2A | Jun 17, 2020 | Issued |
Array
(
[id] => 16361357
[patent_doc_number] => 20200318108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A AND/OR NON-SYNDROMIC AUTOSOMAL RECESSIVE RETINITIS PIGMENTOSA (ARRP)
[patent_app_type] => utility
[patent_app_number] => 16/905258
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905258
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/905258 | Materials and methods for treatment of Usher syndrome type 2A and/or non-syndromic autosomal recessive retinitis pigmentosa (ARRP) | Jun 17, 2020 | Issued |